Science
Cell Biology Medical Research Cell Biology Molecular Biology Medical Research Tissue Engineering Gene Editing Mergers and Acquisitions Healthcare Technology Genomic Technologies
An Innosuisse grant will let PSI’s radiopharmaceutical scientists refine a CD30-targeted terbium-161 therapy before initial human trials.